Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate given as fixed-dose combinations containing emtricitabine as backbones for treatment of HIV-1 infection in virologically suppressed adults: a randomised, double-blind, (Q39870762)
Jump to navigation
Jump to search
scientific article published on 14 March 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate given as fixed-dose combinations containing emtricitabine as backbones for treatment of HIV-1 infection in virologically suppressed adults: a randomised, double-blind, |
scientific article published on 14 March 2016 |
Statements
1 reference
Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate given as fixed-dose combinations containing emtricitabine as backbones for treatment of HIV-1 infection in virologically suppressed adults: a randomised, double-blind, (English)
1 reference
François Raffi
1 reference
Joel E Gallant
1 reference
Eric S Daar
1 reference
Cynthia Brinson
1 reference
Peter Ruane
1 reference
Edwin DeJesus
1 reference
Margaret Johnson
1 reference
Nathan Clumeck
1 reference
Olayemi Osiyemi
1 reference
Doug Ward
1 reference
Javier Morales-Ramirez
1 reference
Mingjin Yan
1 reference
Michael E Abram
1 reference
Andrew Plummer
1 reference
Andrew K Cheng
1 reference
Martin S Rhee
1 reference
14 March 2016
1 reference
1 reference
Identifiers
1 reference